Literature DB >> 34655981

Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy.

Henika Patel1, Pablo Martinez1, Abigail Perkins1, Xavier Taylor1, Nur Jury1, David McKinzie2, Cristian A Lasagna-Reeves3.   

Abstract

Pathological aggregation of tau and neuroinflammatory changes mark the clinical course of Alzheimer's disease and related tauopathies. To understand the correlation between these pathological hallmarks and functional deficits, we assessed behavioral and physiological deficits in the PS19 mouse model, a broadly utilized model of tauopathy. At 9 months, PS19 mice have characteristic hyperactive behavior, a decline in motor strength, and deterioration in physiological conditions marked by lower body temperature, reduced body weight, and an increase in measures of frailty. Correlation of these deficits with different pathological hallmarks revealed that pathological tau species, characterized by soluble p-tau species, and tau seeding bioactivity correlated with impairment in grip strength and thermal regulation. On the other hand, astrocyte reactivity showed a positive correlation with the hyperactive behavior of the PS19 mice. These results suggest that a diverse spectrum of soluble pathological tau species could be responsible for different symptoms and that neuroinflammation could contribute to functional deficits independently from tau pathology. These observations enhance the necessity of a multi-targeted approach for the treatment of neurodegenerative tauopathies.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behavior; Gliosis; Tau pathology; Tauopathy model

Mesh:

Substances:

Year:  2021        PMID: 34655981      PMCID: PMC8671336          DOI: 10.1016/j.neurobiolaging.2021.09.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  66 in total

1.  Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease.

Authors:  Anne K Vehmas; Claudia H Kawas; Walter F Stewart; Juan C Troncoso
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

2.  Tau protein abnormalities associated with the progression of alzheimer disease type dementia.

Authors:  V Haroutunian; P Davies; C Vianna; J D Buxbaum; D P Purohit
Journal:  Neurobiol Aging       Date:  2005-12-15       Impact factor: 4.673

3.  Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease.

Authors:  Alberto Serrano-Pozo; Matthew L Mielke; Teresa Gómez-Isla; Rebecca A Betensky; John H Growdon; Matthew P Frosch; Bradley T Hyman
Journal:  Am J Pathol       Date:  2011-07-21       Impact factor: 4.307

4.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Jose Sarmiento; Juan Troncoso; George R Jackson; Rakez Kayed
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

Review 5.  Reactive astrocyte nomenclature, definitions, and future directions.

Authors:  András Lakatos; James P O'Callaghan; Gabor C Petzold; Alberto Serrano-Pozo; Christian Steinhäuser; Andrea Volterra; Giorgio Carmignoto; Carole Escartin; Elena Galea; Amit Agarwal; Nicola J Allen; Alfonso Araque; Luis Barbeito; Ari Barzilai; Dwight E Bergles; Gilles Bonvento; Arthur M Butt; Wei-Ting Chen; Martine Cohen-Salmon; Colm Cunningham; Benjamin Deneen; Bart De Strooper; Blanca Díaz-Castro; Cinthia Farina; Marc Freeman; Vittorio Gallo; James E Goldman; Steven A Goldman; Magdalena Götz; Antonia Gutiérrez; Philip G Haydon; Dieter H Heiland; Elly M Hol; Matthew G Holt; Masamitsu Iino; Ksenia V Kastanenka; Helmut Kettenmann; Baljit S Khakh; Schuichi Koizumi; C Justin Lee; Shane A Liddelow; Brian A MacVicar; Pierre Magistretti; Albee Messing; Anusha Mishra; Anna V Molofsky; Keith K Murai; Christopher M Norris; Seiji Okada; Stéphane H R Oliet; João F Oliveira; Aude Panatier; Vladimir Parpura; Marcela Pekna; Milos Pekny; Luc Pellerin; Gertrudis Perea; Beatriz G Pérez-Nievas; Frank W Pfrieger; Kira E Poskanzer; Francisco J Quintana; Richard M Ransohoff; Miriam Riquelme-Perez; Stefanie Robel; Christine R Rose; Jeffrey D Rothstein; Nathalie Rouach; David H Rowitch; Alexey Semyanov; Swetlana Sirko; Harald Sontheimer; Raymond A Swanson; Javier Vitorica; Ina-Beate Wanner; Levi B Wood; Jiaqian Wu; Binhai Zheng; Eduardo R Zimmer; Robert Zorec; Michael V Sofroniew; Alexei Verkhratsky
Journal:  Nat Neurosci       Date:  2021-02-15       Impact factor: 24.884

6.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

7.  Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Marcos J Guerrero-Munoz; Takaki Kiritoshi; Volker Neugebauer; George R Jackson; Rakez Kayed
Journal:  Sci Rep       Date:  2012-10-03       Impact factor: 4.379

8.  Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Audra L Clos; George R Jackson; Rakez Kayed
Journal:  Mol Neurodegener       Date:  2011-06-06       Impact factor: 14.195

9.  Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation.

Authors:  Nathalie Daude; Chae Kim; Sang-Gyun Kang; Ghazaleh Eskandari-Sedighi; Tracy Haldiman; Jing Yang; Shelaine C Fleck; Erik Gomez-Cardona; Zhuang Zhuang Han; Sergi Borrego-Ecija; Serene Wohlgemuth; Olivier Julien; Holger Wille; Laura Molina-Porcel; Ellen Gelpi; Jiri G Safar; David Westaway
Journal:  Acta Neuropathol       Date:  2020-03-26       Impact factor: 17.088

10.  Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease.

Authors:  Shorena Janelidze; Erik Stomrud; Ruben Smith; Sebastian Palmqvist; Niklas Mattsson; David C Airey; Nicholas K Proctor; Xiyun Chai; Sergey Shcherbinin; John R Sims; Gallen Triana-Baltzer; Clara Theunis; Randy Slemmon; Marc Mercken; Hartmuth Kolb; Jeffrey L Dage; Oskar Hansson
Journal:  Nat Commun       Date:  2020-04-03       Impact factor: 14.919

View more
  3 in total

1.  Altered Brain Arginine Metabolism and Polyamine System in a P301S Tauopathy Mouse Model: A Time-Course Study.

Authors:  Hannah Mein; Yu Jing; Faraz Ahmad; Hu Zhang; Ping Liu
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

2.  Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.

Authors:  Weijun Ou; Joshua Yang; Juste Simanauskaite; Matthew Choi; Demi M Castellanos; Rudy Chang; Jiahong Sun; Nataraj Jagadeesan; Karen D Parfitt; David H Cribbs; Rachita K Sumbria
Journal:  J Neuroinflammation       Date:  2021-12-31       Impact factor: 8.322

3.  Corpora amylacea are associated with tau burden and cognitive status in Alzheimer's disease.

Authors:  Connor M Wander; Tamy Harumy Moraes Tsujimoto; John F Ervin; Chanung Wang; Spencer M Maranto; Vanya Bhat; Julian D Dallmeier; Shih-Hsiu Jerry Wang; Feng-Chang Lin; William K Scott; David M Holtzman; Todd J Cohen
Journal:  Acta Neuropathol Commun       Date:  2022-08-08       Impact factor: 7.578

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.